Patents/Assignees

Altavant Sciences GmbH

5 patents in portfolio

US11911382utility2024
Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension
0 cites
US11759462utility2023
Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
0 cites
US11708365utility2023
Processes for Preparing TPH1 Inhibitors
0 cites
US11607413utility2023
Dosage Regime and Method for Treating Pulmonary Arterial Hypertension
0 cites
US11576915utility2023
Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension and Daily Dosing
0 cites